Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib monotherapy versus methotrexate in methotrexate-naive rheumatoid arthritis (Phase 3)
2015-003334-27Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of upadacitinib in rheumatoid arthritis (RA) (2 arms), sponsored by AbbVie Inc. Started Nov 2015; status: completed.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2015-003334-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003334-27.